Among the sixteen projects chosen for this year’s Research Forward award is New Avenues to Treat Heart Failure Using an Engineered Enzyme and Human Pluripotent Stem Cells, a collaboration among principal investigator Timothy Kamp (Department of Medicine) and co-principal investigators Philip Romero (Department of Biochemistry), Timothy Kamp (Department of Medicine), Matthew Brown (Department of Surgery), and Aaron LeBeau (Department of Radiology).
Research Forward is a competition sponsored by the Office of the Vice Chancellor for Research and Graduate Education (OVCRGE) intended to stimulate and support highly innovative, collaborative, inclusive, and transformative research at the university. The initiative is supported by the Wisconsin Alumni Research Foundation (WARF) and provides funding for 1–2 years, depending on the needs and scope of the project.
Romero’s Research Forward work aims to open new avenues needed for treatment of heart failure by exploring uses of Angiotensin-Converting Enzyme 2 — a biotherapeutic hormone.
Read more about this year’s Research Forward award recipients.